It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Swine flu: Baxter to make vaccine for British government
Deerfield-based drugmaker also says 2 patient deaths not related to heparin blood thinner
By Bruce Japsen | Tribune reporter
May 16, 2009
Baxter International Inc. on Friday reported that it will make a swine flu vaccine for the British government and said the quality of its heparin blood thinner was not involved in two patient deaths in Delaware.
The United Kingdom Department of Health announced deals with Deerfield-based Baxter and British drug giant GlaxoSmithKline PLC to make up to 90 million doses of a vaccine as a precaution against the H1N1 virus, known as swine flu. Financial terms of the deals were not disclosed.
Originally posted by NKTSL
stop with this flu already i'm sick and tired to hear of it all over... LET IT GO
Originally posted by Fromabove
This so called "pandemic" exists in the mind only. It is "new-speak" of the book "1984". It is meant to be used as a means to further limit individual freedom and allow TPTB to rule by decree.
"The virus is not stoppable," she said. "I would advise them to maintain vigilance, enhance surveillance and be prepared for the arrival of the novel H1N1 in their country."
The U.S. Department of Health and Human Services and the Department of Homeland Security said those agencies have been acting for weeks as if Phase 6 were already in effect and no additional measures would be put into effect.
The United States declared a public health emergency April 26.
"WHO continues to recommend no restriction on travel and on border closures," Chan said.
Discussions about shifting to Phase 6 have been under way for weeks. Chan indicated that a major factor in the decision was surveillance from countries in the Southern Hemisphere, where flu season is under way. In Chile and Australia, two countries with many flu cases, she said H1N1 appears to be the dominant strain, "crowding out" the seasonal influenza virus.
Chan said she would recommend that vaccine manufacturers proceed with mass production of an inoculation against the new swine flu strain as soon as they finish production of seasonal vaccine, which she estimated would be complete in about two weeks.
HHS spokesman Bill Hall said Thursday that no decision has been made on full-scale production because there is no need yet to make that decision.
It is a step-by-step process that is moving forward. "We're doing as much as we can now," he said.
The agency awarded a contract several weeks ago to five manufacturers to develop an H1N1 antigen. The companies are producing pilot lots. Clinical testing will take place over the summer, Hall said.
At the end of the summer, HHS will decide whether to go into production.
"There's no specific date on the calendar," Hall said.
If officials decide to produce a vaccine, the first doses would be ready early in the fall. Hall noted that even full-scale production doesn't mean there will be an immunization campaign. Federal officials may have a vaccine and decide not to use it, he said.